RIPX Inhibitors
RIPX inhibitors, short for Receptor-Interacting Protein Kinase X inhibitors, represent a class of chemical compounds that have gained significant attention in the field of molecular biology and cell signaling research. These inhibitors are designed to target and modulate the activity of a specific group of protein kinases known as receptor-interacting protein kinases (RIPKs), with RIPK1 and RIPK3 being the most extensively studied members within this family. The primary function of RIPKs is to mediate critical cellular processes such as apoptosis, necroptosis, and inflammation in response to various extracellular and intracellular signals.
RIPX inhibitors function by binding to specific regions on RIPKs, thereby interfering with their kinase activity. This interaction can disrupt the downstream signaling cascades initiated by RIPKs, ultimately influencing the fate of the cell. By precisely targeting RIPKs, researchers aim to gain insights into the intricate regulatory mechanisms underlying cell death and inflammation. Additionally, RIPX inhibitors have the potential to elucidate the role of RIPKs in various physiological and pathological conditions, offering a promising avenue for investigating their involvement in disease states and cellular stress responses
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, a kinase that may interact with RUFY3, affecting endosomal dynamics. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that could alter pathways where RUFY3 is involved by impacting signaling cascades. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor that may indirectly affect RUFY3 by altering signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which is part of the MAPK/ERK pathway, potentially influencing RUFY3 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, could modify cellular processes that indirectly involve RUFY3. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which might affect signaling pathways linked with RUFY3 functions. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Disrupts Rac1 activation and might thereby influence RUFY3-associated pathways. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
A CDC42 inhibitor that could alter the dynamics of cellular processes involving RUFY3. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, potentially affecting cellular functions where RUFY3 is relevant. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
A broad-spectrum protein kinase C inhibitor which may impact RUFY3-related pathways. | ||||||